Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christopher Michael Tessier, M.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Christopher Tessier's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Christopher Tessier has written about over time.
Autoimmunity, 1 publications between 2021 and 2021, average publication date March 2021. Diabetes Mellitus, Type 1, 1 publications between 2021 and 2021, average publication date March 2021. Insulin, 1 publications between 2021 and 2021, average publication date March 2021. Insulin-Secreting Cells, 1 publications between 2021 and 2021, average publication date March 2021. Quality of Life, 1 publications between 2021 and 2021, average publication date March 2021. Diabetes Complications, 1 publications between 2021 and 2021, average publication date March 2021. Metabolic Diseases, 1 publications between 2021 and 2021, average publication date March 2021. Nutrition Therapy, 1 publications between 2021 and 2021, average publication date March 2021. Pandemics, 1 publications between 2021 and 2021, average publication date March 2021. Risk Factors, 1 publications between 2021 and 2021, average publication date March 2021. Humans, 3 publications between 2021 and 2021, average publication date April 2021. Hydroxymethylglutaryl-CoA Reductase Inhibitors, 1 publications between 2021 and 2021, average publication date May 2021. Liver Cirrhosis, 1 publications between 2021 and 2021, average publication date May 2021.

To see the data from this visualization as text, click here.
Tessier's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.